Aktie A1C3EQ PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Pacific Biosciences of California, Inc. BOERSE MUENCHEN

Aktien

A1C3EQ

US69404D1081

P09

Realtime BOERSE MUENCHEN
Andere Börsenplätze
 15:14:16 03.07.2024 		% 5 Tage % 1. Jan.
1.194 EUR +1.39% Intraday Chart für Pacific Biosciences of California, Inc. -9.97% -87.43%
27.06. PacBio und Form Bio starten gemeinsam Initiativen zur Vereinheitlichung der AAV-Gentherapie-Industrie MT
27.06. Form Bio und Pacbio kündigen Zusammenarbeit bei der Einführung neuer Ressourcen an, die die Best Practices für AAV-Design und -Analyse verändern sollen CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 2500 Growth Index
PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry
Form Bio and Pacbio Announce Collaboration to Launch New Resources Set to Transform Aav Design and Analysis Best Practices
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
PacBio and International Research Consortium Colors Announce Release of First-Ever HiFi Long-Read Variant Database
Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Pacific Biosciences of California : PacBio Q1 2024 Earnings Presentation
Pacific Biosciences: Q1 Earnings Snapshot
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
PacBio Announces First Quarter 2024 Financial Results
NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries
Sector Update: Health Care Stocks Higher Late Afternoon
Sector Update: Health Care
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1C3EQ Aktie
  4. A1C3EQ Aktie
  5. Nachrichten Pacific Biosciences of California, Inc.
  6. Andere Sprachen